This opportunity funds research on tissue-specific 3D bio-printing of living cells to address challenges in regenerative medicine. It supports projects aiming to develop bio-printing units for human tissue regeneration, including in-situ bio-printing techniques for precise tissue repair. The goal is to enable biomedical scientists and healthcare providers to access advanced tools for treating unmet medical needs and delivering personalized therapies.
Eligible applicants include legal entities established in eligible countries as described in the Horizon Europe Work Programme General Annexes, including entities in the United States. Applicants must meet admissibility, financial, and operational capacity conditions outlined in the programme annexe
